Endoxifen
Showing 1 - 25 of 34
Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ, Stage 0 Breast Cancer AJCC v6 and v7 Trial in Los Angeles,
Active, not recruiting
- Breast Ductal Carcinoma In Situ
- +12 more
- Endoxifen Hydrochloride
- +2 more
-
Los Angeles, California
- +2 more
Mar 8, 2022
Mammographic Breast Density Trial in Stockholm (Topical endoxifen, Placebo)
Completed
- Mammographic Breast Density
- Topical endoxifen
- Placebo
-
Stockholm, Sodersjukhuset, SwedenKarolinska Institutet
Jun 17, 2021
ER+ Breast Cancer Trial in Jakarta (Tamoxifen dose adjustment)
Completed
- ER+ Breast Cancer
- Tamoxifen dose adjustment
-
Jakarta, DKI Jakarta, IndonesiaMRCCC Siloam Hospital Semanggi
Aug 4, 2021
Breast Cancer, DCIS Trial in Germany ((Z)-Endoxifen supplementation according to genotype, (Z)-Endoxifen supplementation
Completed
- Breast Cancer
- DCIS
- (Z)-Endoxifen supplementation according to genotype
- (Z)-Endoxifen supplementation according to plasma levels
-
Salzgitter, Albert-Schweitzer-Straße 18, Germany
- +39 more
Sep 16, 2021
Bipolar I Disorder Trial in Miami (Endoxifen, Placebo oral tablet)
Unknown status
- Bipolar I Disorder
- Endoxifen
- Placebo oral tablet
-
Miami, Florida16420 NW 59 Avenue
Aug 7, 2020
Breast Cancer, Breast Carcinoma, Breast Tumors Trial in Stockholm (Tamoxifen 20 mg)
Active, not recruiting
- Breast Cancer
- +4 more
- Tamoxifen 20 mg
-
Stockholm, SwedenKarolinska University Hospital
May 24, 2022
Breast Cancer Trial in Jakarta (Tamoxifen)
Active, not recruiting
- Breast Cancer
-
Jakarta, DKI Jakarta, IndonesiaMRCCC Siloam Hospitals Semanggi
Aug 12, 2022
Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7 Trial in United States (Endoxifen
Active, not recruiting
- Recurrent Breast Carcinoma
- +5 more
- Endoxifen Hydrochloride
- +3 more
-
Mobile, Alabama
- +566 more
Sep 1, 2021
Tamoxifen in Breast Cancer and in Women at High-Risk of Breast
Active, not recruiting
- Breast Cancer
- +3 more
- citalopram hydrobromide
- +10 more
-
Indianapolis, Indiana
- +3 more
Feb 18, 2022
Breast Tumors Trial in Worldwide (Palbociclib, Placebo, Tamoxifen)
Active, not recruiting
- Breast Neoplasms
- Palbociclib
- +3 more
-
Nagoya, Aichi, Japan
- +22 more
Apr 4, 2022
Breast Cancer Trial in Nijmegen (Tamoxifen 40mg QD)
Completed
- Breast Cancer
- Tamoxifen 40mg QD
-
Nijmegen, NetherlandsRadboud University Nijmegen Medical Centre
Nov 26, 2020
Premenopausal Breast Cancer, Hormone Receptor-positive Breast Cancer Trial in Seoul (drug, diagnostic test, procedure)
Recruiting
- Premenopausal Breast Cancer
- Hormone Receptor-positive Breast Cancer
- Tamoxifen Oral Product
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 14, 2022
CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen
Unknown status
- Breast Cancer
- Tamoxifen 20 mg
- (no location specified)
Jul 3, 2019
Genotyping and Phenotyping of CYP2D6 Breast Cancer Patients on
Unknown status
- Breast Cancer Female
- No intervention
-
Jakarta, DKI Jakarta, IndonesiaDharmais hospital
Apr 23, 2018
Ductal Breast Carcinoma In Situ, Estrogen Receptor Positive Trial in United States (Afimoxifene, Laboratory Biomarker Analysis,
Recruiting
- Ductal Breast Carcinoma In Situ
- Estrogen Receptor Positive
- Afimoxifene
- +3 more
-
Chicago, Illinois
- +5 more
Dec 17, 2020
Prospective Breast Cancer Biobanking
Enrolling by invitation
- Breast Cancer
- Breast Concervative or Meastectomy
-
Stavanger, Rogaland, Norway
- +1 more
Jul 28, 2020
Male Breast Cancer Trial in Essen (Tamoxifen, Tamoxifen and GnRH analogue, Exemestane and GnRH analogue)
Completed
- Male Breast Cancer
- Tamoxifen
- +2 more
-
Essen, Nordrhein-Westfalen, GermanyKliniken Essen-Mitte
Sep 18, 2018
Breath Test for Women Receiving Tamoxifen in Prevention or
Terminated
- Breast Cancer
- dextromethorphan hydrobromide
- +6 more
-
Scottsdale, Arizona
- +1 more
Jan 22, 2018
Varying Doses of Tamoxifen in Setting of Genetic Polymorphisms
Completed
- Breast Cancer
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Aug 24, 2017
Breast Cancer, Menopausal Symptoms Trial in United States (drug, genetic, other, procedure)
Completed
- Breast Cancer
- Menopausal Symptoms
- tamoxifen citrate
- +4 more
-
Chapel Hill, North Carolina
- +6 more
Jul 3, 2017
Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer Trial in Tucson (diindolylmethane, )
Completed
- Stage IA Breast Cancer
- +3 more
- diindolylmethane
- placebo
-
Tucson, ArizonaArizona Cancer Center
Oct 31, 2017